Nael Ismail: Unraveling Genetic Causes of Recurrent Pregnancy Loss
Nael Ismail shared a post on LinkedIn:
“The document discusses two separate studies that used optical genome mapping (OGM) technology to investigate the causes of recurrent pregnancy loss (RPL).
The first study, led by Debopriya Chakraborty, found an average of 40 structural changes in the genomes of RPL patients, and in some cases, these changes directly affected genes linked to RPL and infertility.
The second study, led by Amira Othman, focused on fragile sites in the human chromosome, which are prone to breaks and contribute to genetic instability, and explored their connection to RPL cases.
The document also provides some background information on pregnancy loss, noting that it may occur in up to 25% of all pregnancies, with about half of the cases being caused by genetic or chromosomal issues.
Recurrent pregnancy loss, defined as three or more consecutive pregnancy losses, often has unknown causes, but the new research using OGM technology aims to shed light on these hidden causes.”
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 8, 2025, 06:17New E-Learning Module on Maternal Vaccinations Launched – RCOG
-
Dec 7, 2025, 18:25Thyroid Autoimmunity’s Impact on ART Outcomes Explored – CEOG
-
Dec 7, 2025, 18:23Join Us at the European Parliament on Fertility Crisis – Fertility Europe
-
Dec 7, 2025, 18:20ANDDE Joined The CNPGOGMA – New Era in Gynecology Collaboration – ANDDE
-
Dec 7, 2025, 18:17Gregory Piazza: New Perspectives on Antithrombotic Use During Pregnancy
-
Dec 7, 2025, 18:14New Insights Into Reproductive Health Using AI Technology – CEOG
-
Dec 7, 2025, 18:06Discover Latest Advances at the 2026 Gynecology and Obstetrics Fair – Gynécologie Obstétrique Pratique
-
Dec 7, 2025, 03:12Enhancing Progesterone Signaling in Endometrial Cells – Fertility and Sterility
-
Dec 7, 2025, 03:02Navigating Controversies in Polygenic Embryo Screening – ESHRE